OliX Pharmaceuticals have announced positive results for an siRNA experimental treatment for AMD.
OliX Pharmaceuticals (KOSDAQ: 226950), based in Gyeonggi-do, Seoul, Republic of South Korea, has announced positive results from a phase 1 study evaluating the safety and… Read More »OliX Pharmaceuticals have announced positive results for an siRNA experimental treatment for AMD.